Fibrinolysis-inhibitory capacity of clot-embedded surfactant is enhanced by SP-B and SP-C

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 284, Issue 1 28-1, 2003, Pages

  Markart, Philipp ^a   Ruppert, Clemens ^a   Grimminger, Friedrich ^a   Seeger, Werner ^a   Günther, Andreas ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Acute respiratory distress syndrome; Coagulation; Fibrosis; Hyaline membrane; Pulmonary surfactant; Surfactant protein

Indexed keywords

DIPALMITOYLPHOSPHATIDYLCHOLINE; FIBRIN; LUNG SURFACTANT EXTRACT; PHOSPHOLIPID; PLASMIN; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ARTICLE; CONTROLLED STUDY; DEGRADATION; DOSE RESPONSE; FIBRIN CLOT; FIBRINOLYSIS; HYDROPHOBICITY; LUNG ALVEOLUS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; RABBIT; RESPIRATORY DISTRESS;

EID: 0037213999     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00037.2002     Document Type: Article

References (38)

1. Akiyama SK, Hasegawa E, Hasegawa T, and Yamada KM. The interaction of fibronectin fragments with fibroblastic cells. J Biol Chem 260: 13256-13260, 1985.
2. Aota ST, Nagai T, Olden K, Akiyama SK, and Yamada KM. Fibronectin and integrins in cell adhesion and migration. Biochem Soc Trans 19: 830-835, 1991.
3. Bachofen M and Weibel EF. Structural alterations of lung parenchyma in the adult respiratory distress syndrome. Clin Chest Med 3: 35-56, 1982.
4. Bertozzi P, Astedt B, Zenzius L, Lynch K, LeMaire F, Zapol W, and Chapman HA. Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322: 890-897, 1990.
5. Bittermann PB, Rennard SI, Adelberg S, and Crystal RG. Role of fibronectin as a growth factor for fibroblasts. J Cell Biol 97: 1925-1932, 1983.
6. Bligh EG and Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem 37: 911-917, 1959.
7. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
8. Burkhardt A. Alveolitis and collapse in the pathogenesis of pulmonary fibrosis. Am Rev Respir Dis 140: 513-524, 1989.
9. Campbell EJ, Senior RM, and Welgus HG. Extracellular matrix injury during lung inflammation. Chest 92: 161-167, 1987.
10. Chapman HA, Allen CL, and Stone L. Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis 133: 437-443, 1986.
11. Couchman JR, Austria MR, and Woods A. Fibronectin-cell interactions. J Invest Dermatol 94: 7S-14S, 1990.
12. Gross TJ, Simon RH, and Sitrin RG. Tissue factor procoagulant expression by rat alveolar epithelial cells. Am J Respir Cell Mol Biol 6: 397-403, 1992.
13. Günther A, Bleyl H, and Seeger W. Apoprotein-based synthetic surfactants inhibit plasmic cleavage of fibrinogen in vitro. Am J Physiol Lung Cell Mol Physiol 265: L186-L192, 1993.
14. Günther A, Kalinowski M, Elssner A, and Seeger W. Clot-embedded natural surfactant: Kinetics of fibrinolysis and surface activity. Am J Physiol Lung Cell Mol Physiol 267: L618-L624, 1994.
15. Günther A, Kalinowski M, Rosseau S, and Seeger W. Surfactant incorporation markedly alters mechanical properties of a fibrin clot. Am J Respir Cell Mol Biol 9: 213-220, 1995.
16. Haagsman HP, Sargeant T, Hauschka PV, Benson BJ, and Hawgood S. Binding of calcium to SP-A, a surfactant-associated protein. Biochemistry 29: 8894-8900, 1990.
17. Idell S, Gonzalez K, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JG, Griffith DE, Weiland J, and Martin TR. Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis 136: 1466-1474, 1987.
18. Idell S, James KK, Levin EG, Schwartz BS, Manchanda N, Maunder RJ, Martin TR, McLarty J, and Fair DS. Local abnormalities in coagulation and fibrinolytic pathways. J Clin Invest 84: 695-705, 1989.
19. Idell S, Koenig KB, Fair DS, Martin TR, McLarty J, and Maunder RJ. Serial abnormalities of fibrin turnover in evolving adult respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 261: L240-L248, 1991.
20. Krämer HJ, Schmidt R, Günther A, Becker G, Suzuki Y, and Seeger W. ELISA technique for quantification of surfactant protein B (SP-B) in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 152: 1540-1544, 1995.
21. Kuroki Y, Fukada Y, Takahashi H, and Akino T. Monoclonal antibodies against human pulmonary surfactant apoproteins: Specificity and application in immunoassays. Biochim Biophys Acta 836: 201-209, 1985.
22. Kuroki Y, Mason RJ, and Voelker DR. Alveolar type II cells express a high-affinity receptor for pulmonary surfactant protein. Proc Natl Acad Sci USA 85: 5566-5570, 1988.
23. Lowry OH, Rosebrough NJ, Farr AL, and Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951.
24. McDonald JA. The yin and yang of fibrin in the airways. N Engl J Med 13: 929-931, 1992.
25. Nakstad B, Lyberg T, Skjonsberg OH, and Boye NP. Local activation of the coagulation and fibrinolysis systems in lung disease. Thromb Res 57: 827-838, 1990.
26. Rouser G, Fleischer S, and Yamamoto A. Two-dimensional thin layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots. Lipids 5: 494-496, 1970.
27. Schägger H and von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from I to 100 kDa. Anal Biochem 166: 368-379, 1987.
28. Schmidt R, Steinhilber W, Ruppert C, Daum C, Grimminger F, Seeger W, and Günther A. An ELISA technique for quantification of surfactant apoprotein (SP)-C in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 165: 1-5, 2002.
29. Seeger W, Elssner A, Günther A, Krämer HJ, and Kalinowski HO. Lung surfactant phospholipids associate with polymerizing fibrin: Loss of surface activity. Am J Respir Cell Mol Biol 9: 213-220, 1993.
30. Seeger W, Günther A, Walmrath HD, Grimminger F, and Lasch HG. Alveolar surfactant and adult respiratory distress syndrome. Pathogenetic role and therapeutic prospects. Clin Investig 71: 177-190, 1993.
31. Seeger W, Hübel J, Klapettek K, Pison U, Obertacke U, Joka T, and Roka L. Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress. Thromb Res 61: 53-64, 1991.
32. Sigrist H, Sigrist-Nelson K, and Gitler C. Single-phase butanol extraction: A new tool for proteolipid isolation. Biochem Biophys Res Commun 74: 178-184, 1977.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
34. Unkeless JC, Gordon S, and Reich E. Secretin of plasminogen activator by stimulated macrophages. J Exp Med 139: 834-850, 1974.
35. Van Iwaarden JF, van Berkhout FT, Whitsett JA, Oosting RS, and van Golde LMG. A novel procedure for the rapid isolation of surfactant protein A with retention of its alveolarmacrophage-stimulating properties. Biochem J 309: 551-555, 1995.
36. Warr RG, Hawgood S, Buckley DI, Crisp TM, Schilling J, Benson BJ, Ballard PL, Clements JA, and White RT. Low molecular weight human pulmonary surfactant protein (SP5): Isolation, characterization, and cDNA and amino acid sequences. Proc Natl Acad Sci USA 84: 7915-7919, 1987.
37. Williams MC, Hawgood S, and Hamilton RL. Changes in lipid structure produced by surfactant proteins SP-A, SP-B, and SP-C. Am J Respir Cell Mol Biol 5: 41-50, 1991.
38. Yamada KM. Adhesive recognition sequences. J Biol Chem 266: 12809-12812, 1991.